These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6026478)

  • 21. Topical therapy for oropharyngeal symptoms of myasthenia gravis.
    Dooley JM; Goulden KJ; Gatien JG; Gibson EJ; Brown BS
    Ann Neurol; 1986 Feb; 19(2):192-4. PubMed ID: 3963762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged neonatal myasthenia gravis: electrophysiological studies.
    Branch CE; Swift TR; Dyken PR
    Ann Neurol; 1978 May; 3(5):416-8. PubMed ID: 727721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Problems in the administration of antibiotics to the patients with myasthenia gravis].
    Onishi A; Shida K; Kuroiwa Y
    Naika; 1970 Nov; 26(5):926-9. PubMed ID: 5529430
    [No Abstract]   [Full Text] [Related]  

  • 24. [Myasthenia gravis pseudoparalytica in women in childbed].
    Randelov SA
    Zentralbl Gynakol; 1967 Nov; 89(44):1616-8. PubMed ID: 5589448
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cell electrophoretic studies of lymphocytes. 3. Effects of administration of a massive dosage of prednisolone on lymphocyte functions in myasthenia gravis].
    Noguchi S
    Rinsho Shinkeigaku; 1976 May; 16(5):373-80. PubMed ID: 986275
    [No Abstract]   [Full Text] [Related]  

  • 26. [Electromyography of eye muscles in myasthenia gravis].
    Tietze K; Glatzel W
    Psychiatr Neurol Med Psychol (Leipz); 1980 Feb; 32(2):111-5. PubMed ID: 7394081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Case of systemic lupus erythematosus after thymectomy for myasthenia gravis pseudoparalytica].
    Gietka A; Tłustochowicz W
    Reumatologia; 1982; 20(1-2):61-3. PubMed ID: 7163665
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thymectomy in the therapy of myasthenia gravis pseudoparalytica--anesthesia, preoperative and postoperative care].
    Eckart J
    Dtsch Med J; 1971 Jun; 22(12):399-400. PubMed ID: 5087610
    [No Abstract]   [Full Text] [Related]  

  • 29. [High doses of intravenous gamma globulin in the treatment of myasthenia gravis].
    Fort López-Barajas JM; Ponseti Bosch JM
    Med Clin (Barc); 1988 Sep; 91(9):325-8. PubMed ID: 3216754
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug related crisis in myasthenia gravis.
    Rajasekaran D; Chandrasekar S; Rajendran M
    J Assoc Physicians India; 2006 Oct; 54():820-1. PubMed ID: 17214282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on the flush-phenomenon in intra-arterial administration of pyrrolidino-methyl-tetracycline].
    Schrader CP; Konold P; Schwauwecker F
    Med Welt; 1972 Feb; 23(6):197-9. PubMed ID: 5060487
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prognostic importance of thymic germinating centers in cases of myasthenia gravis pseudoparalytica].
    Schönfelder M; Baumann I
    Psychiatr Neurol Med Psychol (Leipz); 1974 Sep; 26(9):556-64. PubMed ID: 4449919
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myasthenia gravis].
    Rodríguez Arias B
    Rev Esp Otoneurooftalmol Neurocir; 1969 Mar; 28(162):111-5. PubMed ID: 5385147
    [No Abstract]   [Full Text] [Related]  

  • 34. [Myocardial involvement in myasthenia gravis pseudoparalytica].
    Held H; Bass L
    Z Kardiol; 1973 May; 62(5):450-65. PubMed ID: 4724517
    [No Abstract]   [Full Text] [Related]  

  • 35. [Exacerbation of myasthenia gravis by pefloxacin].
    Vial T; Chauplannaz G; Brunel P; Leriche B; Evreux JC
    Rev Neurol (Paris); 1995 Apr; 151(4):286-7. PubMed ID: 7481384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The indication for thymectomy in myasthenia gravis pseudoparalytica].
    Schade G; Ungeheuer E
    Thoraxchir Vask Chir; 1967 Dec; 15(6):668-72. PubMed ID: 5240640
    [No Abstract]   [Full Text] [Related]  

  • 37. [Myasthenia gravis pseudoparalytica and the puerperal state; a case of pregnancy with full-term birth in a patient with myasthenia gravis].
    LAURICELLA E
    Clin Ostet Ginecol; 1956 Apr; 58(2):77-84. PubMed ID: 13330208
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of myasthenia gravis with immune drugs and immunological observations on 31 cases (author's transl)].
    Yu CZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):19-22. PubMed ID: 7307782
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blood levels, excretion and dosage of N-pyrrolidino-methyl-tetracycline (PMT, Reverin) in kidney patients].
    Reubi F
    Klin Wochenschr; 1967 Feb; 45(3):133-7. PubMed ID: 5599557
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimally invasive gastric bypass in a morbidly obese patient with myasthenia gravis.
    Schumann R; Tarnoff M; Siddiqui ZI
    Obes Surg; 2004 Oct; 14(9):1273-6. PubMed ID: 15527647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.